AHR and metabolic dysfunction-associated steatotic liver disease: Our laboratory has recently published that a tryptophan catabolite and an endogenous AhR agonist, cinnabarinic acid (CA) protected against both oleic/palmitic acid treated in vitro and high-fat diet induced in vivo models of NAFLD.